Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;40(2):201-216.
doi: 10.1111/hir.12366. Epub 2021 Feb 18.

Classification of all pharmacological interventions tested in trials relevant to people with schizophrenia: A study-based analysis

Farhad Shokraneh  1   2 , Clive E Adams  2
Affiliations

Classification of all pharmacological interventions tested in trials relevant to people with schizophrenia: A study-based analysis

Farhad Shokraneh et al. Health Info Libr J. 2023 Jun.

Abstract

Background: Systematic reviewing is a time-consuming and resource-intensive process. Information specialists are maintaining study-based registers to facilitate efficient conduct of systematic reviews. Classification of study-level meta-data -such as interventions -can result in much more accurate searches, saving time in the early steps of systematic reviewing.

Objective: To classify all pharmacological interventions from all schizophrenia trials.

Methods: We used Cochrane Schizophrenia's Study-based Register as the source of trials, Emtree and MeSH for synonyms, AdisInsight and CT.gov for research drugs and WHO ATC for marketed drugs.

Results: One third of tested interventions on patients with schizophrenia are pharmacological (816; belonging to 106 clinical classes) with antipsychotic drugs being the most researched (15.1%). Only 528 of these medications are listed in WHO ATC. Around one third of these drug interventions are seen only in research (236; from 21 pharmacological/biochemical classes). Within the pharmacological interventions, we identified 28 'qualifiers' including dose, route and timing of drug delivery.

Conclusion: Identification and classification of pharmacological interventions from trials require use of many sources of information none of which are inclusive of all drugs. Limitations of each source are helpful to understand. Classification of non-pharmacological interventions is now a priority for clinical and information scientists and professionals.

Keywords: classification; randomised controlled trial (RCT); review; search strategies; systematic - as topic.

PubMed Disclaimer

References

REFERENCES

    1. Abbas, F., Rajab, T., Alsamarrai, O., Alhalabi, N., Zaher Addeen, S., Mheish, O., Aljojo, A., & Essali, A. (2017). Fluphenazine decanoate (timing of administration) for people with schizophrenia. Cochrane Database of Systematic Reviews, 2017(10), CD012810. https://doi.org/10.1002/14651858.cd012810
    1. Adams, C., & Gelder, M. (1994). The case for establishing a register of randomised controlled trials of mental health care. A widely accessible register will minimise bias for those reviewing care. British Journal of Psychiatry, 164(4), 433-436.
    1. Bachrach, C. A., & Charen, T. (1978). Selection of MEDLINE contents, the development of its thesaurus, and the indexing process. Medical Informatics (London), 3(3), 237-254.
    1. Bannister, J. A., Adams, C. E., & Shokraneh, F. (2019). The lost drugs of schizophrenia. British Association for Psychopharmacology Summer Meeting; 14-17 July 2019; Manchester, UK.
    1. Bazrafshan, A., Zare, M., Okhovati, M., & Shamsi Meimandi, M. (2015). Acetophenazine versus chlorpromazine for schizophrenia. Cochrane Database of Systematic Reviews, 2015(4), CD011662. https://doi.org/10.1002/14651858.cd011662

MeSH terms

Substances

LinkOut - more resources